dc.contributor.author | Menekse, S. | |
dc.contributor.author | Aydin, M. | |
dc.contributor.author | Ergonul, O. | |
dc.contributor.author | Azap, A. | |
dc.contributor.author | Bilgin, H. | |
dc.contributor.author | Aydin, G. | |
dc.contributor.author | Cavus, S. A. | |
dc.contributor.author | Demiroglu, Y. Z. | |
dc.contributor.author | Aliskan, H. E. | |
dc.contributor.author | Memikoglu, O. | |
dc.contributor.author | Kaya, S. | |
dc.contributor.author | Demir, N. A. | |
dc.contributor.author | Karaoglan, I. | |
dc.contributor.author | Tezer, Y. | |
dc.contributor.author | Demirkaya, H. | |
dc.contributor.author | Cakar, S. E. | |
dc.contributor.author | Keske, S. | |
dc.contributor.author | Tekin, S. | |
dc.contributor.author | Yardimci, C. | |
dc.contributor.author | Karakoc, C. | |
dc.contributor.author | Basaran, Seniha | |
dc.contributor.author | Ergen, P. | |
dc.contributor.author | Azap, O. | |
dc.contributor.author | Mulazimoglu, L. | |
dc.contributor.author | Ural, O. | |
dc.contributor.author | Can, F. | |
dc.contributor.author | Akalin, H. | |
dc.contributor.author | Yilmaz, E. | |
dc.contributor.author | Hatipoglu, C. | |
dc.contributor.author | Erdinc, S. | |
dc.contributor.author | Tumturk, A. | |
dc.date.accessioned | 2021-03-05T12:06:34Z | |
dc.date.available | 2021-03-05T12:06:34Z | |
dc.date.issued | 2018 | |
dc.identifier.citation | Aydin M., Ergonul O., Azap A., Bilgin H., Aydin G., Cavus S. A. , Demiroglu Y. Z. , Aliskan H. E. , Memikoglu O., Menekse S., et al., "Rapid emergence of colistin resistance and its impact on fatality among healthcare-associated infections.", The Journal of hospital infection, cilt.98, ss.260-263, 2018 | |
dc.identifier.issn | 0195-6701 | |
dc.identifier.other | vv_1032021 | |
dc.identifier.other | av_ab7c5969-3040-48d0-b2ec-a652bdd57beb | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/114485 | |
dc.identifier.uri | https://doi.org/10.1016/j.jhin.2017.11.014 | |
dc.description.abstract | This article describes the emergence of resistance and predictors of fatality for 1556 cases of healthcare-associated Gram-negative bloodstream infection in 2014 and 2015. The colistin resistance rate in Klebsiella pneumoniae was 16.1%, compared with 6% in 2013. In total, 660 (42.4%) cases were fatal. The highest fatality rate was among patients with Acinetobacter baumannii bacteraemia (58%), followed by Pseudomonas aeruginosa (45%), Klebsiella pneumoniae (41%), Enterobacter cloacae (32%) and Escherichia coli (28%). On multi-variate analysis, the minimum inhibitory concentrations for carbapenems [odds ratio (OR) 1.02, 95% confidence interval (CI) 1.01-1.04; P = 0.002] and colistin (OR 1.1, 95% CI 1.03-1.17; P = 0.001) were found to be significantly associated with fatality. (C) 2017 The Healthcare Infection Society. Published by Elsevier Ltd. All rights reserved. | |
dc.language.iso | eng | |
dc.subject | Sosyoloji | |
dc.subject | Yaşam Bilimleri | |
dc.subject | Temel Bilimler | |
dc.subject | Sosyal Bilimler Genel | |
dc.subject | Sosyal Bilimler (SOC) | |
dc.subject | BULAŞICI HASTALIKLAR | |
dc.subject | İmmünoloji | |
dc.subject | Yaşam Bilimleri (LIFE) | |
dc.subject | Sosyal ve Beşeri Bilimler | |
dc.subject | KAMU, ÇEVRE VE İŞ SAĞLIĞI | |
dc.title | Rapid emergence of colistin resistance and its impact on fatality among healthcare-associated infections. | |
dc.type | Makale | |
dc.relation.journal | The Journal of hospital infection | |
dc.contributor.department | Başkent Üniversitesi , , | |
dc.identifier.volume | 98 | |
dc.identifier.issue | 3 | |
dc.identifier.startpage | 260 | |
dc.identifier.endpage | 263 | |
dc.contributor.firstauthorID | 252193 | |